Abstract

Oral Sessions

Day 2: Thursday, June 18 9:30-9:50 Room B(102)

An assay of pyrimidine metabolites by UPLC/MS/MS

(1Nagoya City Univ., 2Fujita Health Univ.)
oYasuhiro Maeda1, Yoko Nakajima2, Tetsuya Ito2

Inborn error of pyrimidine metabolism is one of inherited metabolic diseases and due to synthetic or catabolic enzyme defect. This disease shows various symptoms such as severe developmental disorder, hypotonia, microcephaly and so on. The number of cases lack, and the details such as onset frequency or the gene variation are unclear, and the accumulation of the further case is required. We developed a simultaneous determination method of metabolites accumulated for dihydropyrimidine dehydrogenase (DPDase) deficiency, dihydropyrimidinase (DHPase) deficiency and ureidopropionase (UPase) deficiency by UPLC/MS/MS. When urine samples of DHPase deficiency and UPase deficiency patients were analyzed by this method, highly-concentrated metabolites were excreted by comparing with control samples.